Coronavirus vaccine: DCGI gives nod to Serum-Oxford for phase 2, 3 clinical trials in India
DCGI has allowed the Serum Institute of India to conduct phase 2 and 3 human clinical trials in India on the potential COVID19 vaccine.
Full Article
Coronavirus vaccine: DCGI gives nod to Serum-Oxford for phase 2, 3 clinical trials in India
DNA
0 shares
1 views
You might like
Related news coverage
Phase II trial of Oxford COVID-19 vaccine candidate to begin in PGI Chandigarh
Mid-Day
The Post Graduate Institute of Medical Education and Research (PGIMER) in Chandigarh will be beginning the Phase II trial of oxford..
-
COVID-19 vaccine: Happy to be part of noble, global effort, says Pune trial volunteer
Mid-Day
-
Russia in touch with India for collaboration to manufacture COVID-19 vaccine Sputnik V: Health Ministry
Mid-Day
-
Phase 2 trial of Oxford COVID-19 vaccine candidate to begin today
Mid-Day
-
The Latest: Pakistan reports fewest virus deaths since March
SeattlePI.com
Advertisement
More coverage
ICMR developing portal for information on COVID-19 vaccine
Mid-Day
The apex health research body, ICMR, is in the process of developing a vaccine portal which will provide information related to the..
-
COVID-19: India to have coronavirus vaccine by 2020 end, says Harsh Vardhan
Mid-Day
-
Will the superfast 'Sputnik V' vaccine put citizens at risk?
Mid-Day
-
Post-Covid complications a new dimension, have to be aware: Niti Aayog member
Mid-Day
-
COVID-19 vaccine candidate to enter phase-3 human trial: Health Ministry
Mid-Day